AHFS Drug Information (AHFS DI) is a leading source of evidence-based drug information.

AHFS DI is a dependable, comprehensive and objective database for FDA approved drug products. Inclusion of evidence-based data on labelled and unlabelled drug use makes this a valuable reference for healthcare professionals seeking to provide their patients with safe and effective therapy.

AHFS DI is published by the American Society of Health-System Pharmacists (ASHP).

SubscribeContent Updates
Features and Benefits icon

Comprehensive: Highly detailed monographs with extensive information on the chemistry and clinical application of all FDA approved drugs

Features and Benefits icon

Evidence-based: Built on evidence from primary sources and peer reviewed by over 500 pharmacists, physicians and healthcare professionals

Features and Benefits icon

Dependable: Fast and easy access to content that is revalidated, revised and updated regularly as new information arrives

Features and Benefits icon

Objective: The information is compiled without any influence from manufacturers, insurers, regulators or other interested parties

Publication Updates

14 Jan
AHFS Drug Information logo
AHFS Jan 2020 Update

This update contains 2 new monographs, 47 revised monographs, and 1 discontinued monograph. 

New monographs: Elexacaftor, Tezacaftor, And Ivacaftor; Minocycline (Topical) 

Revised monographs: Insulin Aspart; Zoledronic Acid; Mycophenolate; Exenatide; Mometasone; Glatiramer; Human Papillomavirus Vaccine; SITagliptin; Febuxostat; Liraglutide; Fingolimod; sAXagliptin; Linagliptin; Tofacitinib; Alogliptin; Canagliflozin; Teriflunomide; Dimethyl Fumarate; Dapagliflozin; Dulaglutide; Empagliflozin; Alemtuzumab; Peginterferon Beta-1a; Lixisenatide; Insulin Degludec; Ocrelizumab; Latanoprostene bunod; Netarsudil mesylate; Ertugliflozin; Angiotensin II; Fremanezumab-vfrm; Galcanezumab-gnlm; Cenegermin-bkbj; Esketamine; Phenytoin; LORazepam; Tamoxifen; hydroCHLOROthiazide; Allopurinol; Benzodiazepines General Statement; Insulins General Statement; Insulin Human; Midazolam; Interferon Beta; metFORMIN; mitoXANTRONE; Raloxifene 

Discontinued monographs: antineoplastic agents GS 

10 Dec
AHFS Drug Information logo
AHFS December 2019 Update

This update contains 3 new monographs, 45 revised monographs, and 1 discontinued monograph. 

New monographs:  

Brolucizumab-dbll; Tenapanor; Trifarotene 

Revised monographs: 

Fosphenytoin; Propofol; Etomidate; Influenza Vaccine Live Intranasal; Eszopiclone; Clevidipine; Rivaroxaban; Influenza Vaccine Recombinant; Apixaban; Pembrolizumab; Evolocumab; Venetoclax; idaruCIZUmab; Brexpiprazole; Cariprazine; Betrixaban; Factor Xa (recombinant), Inactivated-zhzo; Lofexidine; Cannabidiol; Duvelisib; Lorlatinib; Gilteritinib; Prucalopride; Ketamine; Phenytoin; diazePAM; Morphine; Methadone; cloNIDine; Phenylephrine; Pentazocine; fentaNYL; Spironalactone; Opium Preparations; Aspirin; Phenothiazines General Statement; Opiate Agonists General Statement; Anticonvulsants General Statement; Tricyclic Antidepressants General Statement; Antimuscarinics/Antispasmodics General Statement; amLODipine; Zolpidem; Influenza Virus Vaccine Inactivated; Zalepon 

Discontinued monographs:  

Mepenzolate 

12 Nov
AHFS Drug Information logo
AHFS November 2019 Update

This update contains 7 new monographs, 35 revised monographs, 2 discontinued monographs and 2 new MedWatch alerts.

New monographs: Darolutamide; Pexidartinib; Upadacitinib.

Revised monographs: Moxifloxacin; Entacapone; valGANciclovir; Tegaserod; Denosumab; Tofacitinib; Baricitinib; Cemiplimab-rwlc; Baloxavir; Nitroglycerin; Preface to Penicillins; Ganciclovir; Foscarnet; Cidofovir; levoFLOXacin.

Discontinued monographs: Extended-spectrum penicillins GS; Cardiac glycosides GS. 

New MedWatch alerts on the following monographs:  Elbasvir and Grazoprevir; Sofosbuvir, Velpatasvir, and Voxilaprevir; Glecaprevir and Pibrentasvir; Palbociclib; Ribociclib; Abemaciclib. 

08 Oct
AHFS Drug Information logo
AHFS October 2019 Update

This update contains 3 new monographs and 15 revised monographs.

New monographs: Darolutamide; Pexidartinib; Upadacitinib.

Revised monographs: Moxifloxacin; Entacapone; valGANciclovir; Tegaserod; Denosumab; Tofacitinib; Baricitinib; Cemiplimab-rwlc; Baloxavir; Nitroglycerin; Preface to Penicillins; Ganciclovir; Foscarnet; Cidofovir; levoFLOXacin.

10 Sep
AHFS Drug Information logo
AHFS September 2019 Update

This update contains 5 new monographs and 72 revised monographs.

New monographs: Solriamfetol; Polatuzumab Vedotin; Amifampridine; Bremelanotide; Selinexor.

Revised monographs: Gefitinib; Erlotinib; Nabilone; Ceftaroline; Afatinib; Osimertinib; Bezlotoxumab; Becaplermin; Erenumab-aooe; Dacomitinib; Talazoparib; Amifampridine; Ketamine; Doxycycline; Tetracycline; Minocycline; Demeclocycline; sulfADIAZINE; sulfaSALAzine; Sodium Nitroprusside; Prazosin; Erythromycin Ethylsuccinate; Erythromycin; Menotropins; Tobramycin; Amikacin; Neomycin; Gentamicin; Streptomycin; Cefaclor; Cefadroxil; ceFAZolin; Cephalexin; Cefotaxime; Erythromycin Lactobionate; Erythromycin Stearate; Furosemide; Insulins General Statement; dilTIAZem; Cefuroxime; Bumetanide; Amoxicillin; Ampicillin; Penicillin G Benzathine; Penicillin G Potassium, Penicillin G Sodium; Penicillin G Procaine; Penicillin V; Dicloxacillin; Nafcillin; Oxacillin; Amoxicillin/Clavulanate; cefTRIAXone; cefTAZidime; Digoxin Immune Fab; Enalapril; Buprenorphine; Cefixime; Clarithromycin; Benazepril; amLODIPine; Lisinopril; Ampicillin/Sulbactam; Terazosin; Isradipine; Piperacillin and Tazobactam; niCARdipine; Azithromycin; Cefdinir; Cefepime; Cefprozil; Cefprozil; Ceftibuten; Cefpodoxime

13 Aug
AHFS Drug Information logo
AHFS August 2019 Update

This update contains 4 new monographs and 26 revised monographs.

New monographs: Ropivacaine; Ketamine; Alpelisib; Brexanolone

Revised monographs: Nitazoxanide; Vaccinia Immune Globulin IV; Tapentadol; Fidaxomicin; Letermovir; Ozenoxacin; Burosumab-twza; Dehydrated Alcohol; Patisiran; Galcanezumab-gnlm; Gilteritinib; HYDROcodone; HYDROmorphone; Levorphanol; Codeine; Meperidine; oxyCODONE; Chloramphenicol; Flucytosine; Pentazocine; Levodopa/Carbidopa; Benzocaine; Butorphanol; Local Anesthetics, Parenteral, General Statement; Nicotine; traMADol

View more View all content updates